Best Cardiac and Vascular Disorders Companies in Florida, United States
The 42 best Cardiac and Vascular Disorders companies in Florida, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Concept Medical.
Ranked: Best Cardiac and Vascular Disorders companies in Florida
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Concept Medical Developer of devices for treating cardiac disorders and diabetes | $60M | 96 mo ago | Series C | Kumaresan Pandurangan CISO & Director Of Information Technology | 2008 | WordPressPleskMySQL+29 | — | — |
| 2 | Stem Cell Provides cell therapies, intelligent devices and biologics for chronic heart failure patients | $33M | 103 mo ago | Public | Mike Tomas President & CEO | 1999 | — | — | — |
| 3 | Vascular Pathways Guidewire for Peripheral vascular line insertion | $20M | 146 mo ago | Acqui-Hired | Gene Starr CEO | 2005 | — | 88 patents Intravenous catheter insertion devices that minimize blood spatter during placement | — |
| 4 | AventuSoft Cloud connected wearable to detect heart related abnormalities 11Moat top 32%Funding top 39%Patents bottom 49%Talent bottom 45% All 8 signals ▾Moattop 32% Fundingtop 39% Patentsbottom 49% Talentbottom 45% Innovationbottom 38% Techbottom 35% Globalbottom 31% Marketbottom 10% Moat: Editorial + unicorn rating 4/10 · IP moat: 26 patents Funding: Raised $13.7M across 10 rounds · 10 rounds over 13 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 11/100 | $14M | 11 mo ago | Funding Raised | Kaustubh Kale Founder & CEO | 2013 | — | 26 patents Patents concentrated in health & consumer products | — |
| 5 | Bongiovi Medical Advanced audio technologies improving healthcare outcomes and reducing costs | $10M | 144 mo ago | Deadpooled | Tony Bongiovi Founder & MD | 2012 | — | — | — |
| 6 | Ambulero Developer of cell & gene therapies for the treatment of rare vascular disease and critical limb ischemia | $6M | 38 mo ago | Seed | Robert Buchanan Co-founder | 2019 | — | — | — |
| 7 | SwiftSync Developer of a medical device for temporary A-V sequential pacing catheter | $5M | 30 mo ago | Series A | Eduardo DeMarchena Co-Founder | 2021 | — | — | — |
| 8 | NativeCardio Developer of a cardiovascular device for postoperative atrial fibrillation | $3M | 18 mo ago | Seed | Joseph Pergolizzi CEO | 2018 | — | — | — |
| 9 | ICHOR Vascular Developer of a device to treat limb ischemia | $3M | 31 mo ago | Seed | Sean Morris CEO | 2015 | — | — | — |
| 10 | SafeCross Developer of a medical device for catheter-based cardiac procedures | $2M | 76 mo ago | Seed | — | 2017 | — | — | — |
| 11 | Native Cardio Developer of a cardiac device for treating atrial fibrillation | $2M | 90 mo ago | Series A | Young Kim Co-Founder | 1950 | — | — | — |
| 12 | Longeveron Developer of cellular therapies for aging-related and life-threatening conditions | $1M | 5 mo ago | Public | Joshua Hare Co-Founder | 2014 | WordPressMySQLPHP+18 | 84 patents Mesenchymal stem cell therapies and potency assays for neurodegenerative and immune disorders | — |
| 13 | Immorta Bio Developer of personalized stem cell platforms for organ-specific regeneration | $450K | 33 mo ago | Seed | Boris Reznik CEO | 2023 | WebflowreCAPTCHAHSTS+10 | — | — |
| 14 | Cadrenal Therapeutics Developer of therapeutics for renal disease and atrial fibrillation | $400K | 37 mo ago | Public | Quang Pham Founder & CEO | 2022 | WordPressMySQLPHP+21 | — | 1 launch |
Top 12 Cardiac and Vascular Disorders companies in Florida
#1
Funding Raised · Boca Raton, Florida · founded 2013 · 4 employees$13.7Mraised▾
AventuSoft is developing a cloud-connected wearable device that can be used to monitor heart rate for detecting heart-related abnormalities. The company has filed a patent for a device that can monitor the functioning of the human heart by monitoring and tracking heart beats. The company has also developed a cloud-based solution for speech analysis to detect and analyse speech disorders.
- Sep 2025Grant (prize money)$349.9K
- Apr 2025Grant (prize money)$2.1M
- Apr 2023Grant (prize money)$1.3M
- Apr 2020Grant (prize money)$3.7M
#2
Public · Miami, Florida · founded 2014 · 23 employees$1.1Mraised▾
Developer of cellular therapies for aging-related and life-threatening conditions. The company's product include Lomecel-B is derived from culture-expanded medicinal signaling cells harvested from the bone marrow of adult human donors. It is used for the treatment of aging frailty, Alzheimer’s disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome.
- Mar 2026Post IPO$15.9M
- Dec 2021Post IPO$20.5M
- Feb 2020Seed$100K
- Nov 2018Grant (prize money)$6.7M
#3
Seed · Naples, Florida · founded 2018$3Mraised▾
Developer of a cardiovascular device for postoperative atrial fibrillation. It offers technology to develop minimally invasive medical devices to treat patients and deliver drugs to alleviate or remove the unwanted systemic side effects associated with these drugs
- Feb 2025Seed$150K
- Mar 2023Seed$465K
- May 2021Seed$70K
- Jan 2021Seed$2.5M
#4
Series A · Miami, Florida · founded 2021 · 3 employees$5Mraised▾
Developer of a medical device for temporary A-V sequential pacing catheter. It improves heart rhythm emergencies, cardiac surgeries, and interventional cardiology outcomes by re-establishing cardiac rhythm and improving heart output.
- Jan 2024Series A$1.5M
- May 2021Series A$3.5M
#5
Series C · Tampa, Florida · founded 2008$60Mraised▾
Developer of devices for treating cardint for people suffering from diabetes. It offers sirolimus-based drug delivery technologies which include Albuminus a polymer-based nano-carrier eluting stent for the treatment of coronary artery diseases, and MagicTouch a sirolimus coated balloon catheter for treating arterial venous fistula, coronary artery diseases, and peripheral arterial diseases, and diabetes.
- Aug 2018Series C$60M
- Aug 2018Conventional Debt—
- May 2017Seed$75K
- Aug 2011Seed$600K
#6
Seed · Boca Raton, Florida · founded 2015 · 2 employees$2.9Mraised▾
Developer of a device to treat limb ischemia. The company has developed a minimally invasive percutaneous arterial embolectomy system for treating peripheral arterial disease (PAD) in the lower limbs.
- Jan 2024Seed$2.9M
#7
Seed · Miami, Florida · founded 2019 · 5 employees$5.5Mraised▾
Developer of cell & gene therapies for the treatment of rare vascular disease and critical limb ischemia. The company is involved in the development of a regenerative cell that delivers E-selectin adhesion molecules to vascular tissues damaged by disease. Its lead candidate AMB-101 that helps in treating a rare form of vascular disease striking the limbs of young people. It also provides gene therapeutic candidate AMB-202 that delivers E-selectin directly to ischemic tissues and helps in treating critical limb ischemia of diabetic patients.
- Jun 2023Grant (prize money)—
- Jan 2021Seed$5.5M
#8
Public · Sunrise, Florida · founded 1999 · 15 employees$33.1Mraised▾
Stem Cell (formerly Bioheart) specializes in delivering cell therapies, intelligent devices and biologics that help address congestive heart failure, lower limb ischemia, chronic heart ischemia, acute myocardial infarctions and other issues. The Company works to prevent the worsening of any condition employing devices that monitor and diagnose. The Company is focused on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease, subject to regulatory approval. MyoCell, the Company's principal therapy, is a clinical muscle-derived cell therapy designed to populate regions of scar tissue within a patient's heart with new living cells for the purpose of improving cardiac function in chronic heart failure patients.
#9
Acqui-Hired · Naples, Florida · founded 2005 · 8 employees$19.5Mraised▾
Vascular pathways develops and commercializes vascular access devices. Its proprietary AccuCath Intravenous Catheters are used to sample blood, monitor blood pressure, or administer fluids intravenously.These devices employ FDA approved Nitinol guidewire technology and address all situations where peripheral IV access is required. As of July 1, 2015, Vascular Pathways, Inc. operates as a subsidiary of CR Bard.
- Jun 2014Conventional Debt$5M
- May 2014Series B$5.5M
- May 2012Series B$14M
#10
Deadpooled · Port St Lucie, Florida · founded 2012$10.1Mraised▾
Advanced audio technologies improving healthcare outcomes and reducing costs. They are dedicated to enhancing patient care through innovative audio solutions and next-generation applications. They specialize in immersive audio solutions for healthcare, therapy, education, and entertainment. Their technology includes non-invasive auscultative tests for carotid health, MDPS technology for enhanced audio clarity, and AMI (Audio Machine Intelligence) for medical applications. They offer solutions for voice intelligibility in noisy environments, virtual reality therapy, and a universal system for medical condition analysis. Their products include the Aria Stethoscope and telemedicine solutions, focusing on AI analysis and improved speech intelligibility. They partner with industry leaders to provide dynamic and cost-effective diagnostic solutions.
- Aug 2014Series A$5M
- Aug 2014Series A$5M
#11
Seed · Miami Beach, Florida · founded 2023$450Kraised▾
Developer of personalized stem cell platforms for organ-specific regeneration. The company leverages personalized progenitor cells to develop practical stem cell platforms aimed at treating diseases of aging and treating aging as a disease.
- Nov 2023Seed$450K
#12
Public · Ponte Vedra Beach, Florida · founded 2022 · 3 employees$400Kraised▾
Developer of therapeutics for renal disease and atrial fibrillation. It offers a lead candidate Tecarfarin is an anticoagulation drug for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.
- Jul 2023Post IPO—
- Dec 2022Seed$250K
- Jul 2022Seed$150K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Cardiac and Vascular Disorders coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.